These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8253075)

  • 1. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.
    Owczarek CM; Layton MJ; Metcalf D; Lock P; Willson TA; Gough NM; Nicola NA
    EMBO J; 1993 Sep; 12(9):3487-95. PubMed ID: 8253075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction.
    Layton MJ; Lock P; Metcalf D; Nicola NA
    J Biol Chem; 1994 Jun; 269(25):17048-55. PubMed ID: 8006010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain.
    Owczarek CM; Zhang Y; Layton MJ; Metcalf D; Roberts B; Nicola NA
    J Biol Chem; 1997 Sep; 272(38):23976-85. PubMed ID: 9295349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues.
    Layton MJ; Owczarek CM; Metcalf D; Clark RL; Smith DK; Treutlein HR; Nicola NA
    J Biol Chem; 1994 Nov; 269(47):29891-6. PubMed ID: 7961984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
    Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
    Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists.
    Hudson KR; Vernallis AB; Heath JK
    J Biol Chem; 1996 May; 271(20):11971-8. PubMed ID: 8662595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-species chimeras of leukemia inhibitory factor define a human receptor binding site.
    Owczarek CM; Layton MJ; Metcalf D; Clark R; Gough NM; Nicola NA
    Ann N Y Acad Sci; 1995 Jul; 762():165-78. PubMed ID: 7668527
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M; Hara T; Kim H; Murate T; Miyajima A
    Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
    Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
    Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor.
    Gearing DP; VandenBos T; Beckmann MP; Thut CJ; Comeau MR; Mosley B; Ziegler SF
    Ciba Found Symp; 1992; 167():245-55; discussion 255-9. PubMed ID: 1425017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
    Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
    Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex binding of leukemia inhibitory factor to its membrane-expressed and soluble receptors.
    Layton MJ; Owczarek CM; Metcalf D; Lock PA; Wilson TA; Gough NM; Hilton DJ; Nicola NA
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):295-8. PubMed ID: 8016167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of murine leukemia inhibitory factor.
    Robinson RC; Grey LM; Staunton D; Stuart DI; Heath JK; Jones EY
    Ann N Y Acad Sci; 1995 Jul; 762():179-87; discussion 187-8. PubMed ID: 7668528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
    Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
    J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human germ cell tumor cell lines express novel leukemia inhibitory factor transcripts encoding differentially localized proteins.
    Voyle RB; Haines BP; Pera MF; Forrest R; Rathjen PD
    Exp Cell Res; 1999 Jun; 249(2):199-211. PubMed ID: 10366419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
    Blanchard F; Raher S; Duplomb L; Vusio P; Pitard V; Taupin JL; Moreau JF; Hoflack B; Minvielle S; Jacques Y; Godard A
    J Biol Chem; 1998 Aug; 273(33):20886-93. PubMed ID: 9694835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.